BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Ralph J. Abi‐Habib(Wake Forest University), Arthur E. Frankel(The University of Texas Southwestern Medical Center)
Cited by 73
Related Papers
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
|Biomarker Research|2014|249
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
|Nature Communications|2016|69